Reponen Initiated as New Member of ISIAQ Academy of Fellows
Tiina Reponen, PhD, a professor in the UC Department of Environmental Health, has been initiated as a new member of the ISIAQ (International Society of Indoor Air Quality and Climate) Academy of Fellows.
The Academy is an international, multidisciplinary, scientific honorary organization established to promote scholarship for indoor environmental and building sciences. Membership is by invitation, following a nomination and election procedure. Reponen was initiated July 7 at the Indoor Air 2014 conference in Hong Kong.
Reponen is the director of the University of Cincinnati Education and Research Center, which is funded by the National Institute for Occupational Safety and Health and housed in the UC Department of Environmental Health. She teaches in the Environmental and Occupational Health graduate program.
Her research is focused on the exposure assessment of bioaerosols in indoor and industrial environments, including physical and microbiological characterization of airborne actinomycete and fungal spores, the dispersion of bioaerosols under natural and laboratory conditions, and the control of airborne microorganisms by filtration.
Reponen is currently directing two cohort studies. One is focused on the association between indoor bioaerosol exposures and the development of childrens allergy and asthma, and the other is focused on the effects of green renovation on indoor air quality and occupants health.
She is a recipient of Finland Distinguished Professor award.
Tags
Related Stories
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.
Why can it get so hot at times?
September 3, 2026
Cincinnati is experiencing more days of extreme heat this summer than in previous decades, due in large part to warmer global temperatures. But explanations for these higher temperatures also relate to regional factors, including the city's location in a river valley and large proportion of built environment.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.